DALLAS, TX, Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round-led by WAVE Ventures.
Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round-led by WAVE Ventures and supported by Pathway to Cures-to accelerate the development of its bioelectronic treatments, supporting the core areas of its business: neurological health, hemostasis, and women's health.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
